NexTel Medical Corp. Advances Veterinary Oncology Strategy with Rollout of Early-Stage Cancer Screening for Companion AnimalsCompany targets a growing $1.2B+ North American pet oncology market leveraging proprietary exosome-based diagnostic technologies.
